Cover Image

Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis

Background: The association of patient and prescriber characteristics with use of warfarin versus direct-acting oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) and chronic kidney disease (CKD) is not well studied. Methods: The 20% Centers for Medicare & Medicaid Services Pa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jorge L. Reyes MD (Author), Charles A. Herzog MD (Author), Heng Yan MS (Author), Nicholas S. Roetker PhD (Author), James B. Wetmore MD, MS (Author)
Format:	Book
Published:	SAGE Publishing, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prescribers' perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation
by: Daria Generalova, et al.
Published: (2020)

Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis
by: Estella Davis, et al.
Published: (2020)

Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery
by: Dannick Brochu PharmD, et al.
Published: (2022)

Usability of an Atrial Fibrillation Anticoagulation Decision-Support Tool
by: Mark L. Wess MD, SM, et al.
Published: (2011)

Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: V. I. Petrov, et al.
Published: (2019)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
by: Gustafson WL, et al.
Published: (2019)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021)

Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
by: Catherine Yao, et al.
Published: (2022)

Gender Related Differences in Gastrointestinal Bleeding With Oral Anticoagulation in Atrial Fibrillation
by: Eliana Ferroni MD, et al.
Published: (2022)

Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation
by: Caroline Brais, et al.
Published: (2017)

Gastrointestinal protection options for direct oral anticoagulants in patients with atrial fibrillation
by: Natalya M. Vorobyeva, et al.
Published: (2022)

Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation
by: S. V. Malchikova, et al.
Published: (2020)

Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study
by: Justin J. Song MD, et al.
Published: (2024)

Oral anticoagulation in patients with atrial fibrillation and end-stage kidney disease
by: Tânia B. Azevedo, et al.
Published: (2022)

Anticoagulation Patterns Among Community-Dwelling Older Adults With Atrial Fibrillation
by: Meaghan Costello, et al.
Published: (2024)

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
by: Soo Min Jang, et al.
Published: (2020)

Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality
by: Łukasz Pyka MD, PhD, et al.
Published: (2023)

NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING
by: Zh. D. Kobalava, et al.
Published: (2018)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
by: Joseph M. Harburger, et al.
Published: (2012)

Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
by: I. S. Daabul, et al.
Published: (2016)

NEW ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE
by: E. P. Panchenko
Published: (2015)

Systematic Review of Medicine-Related Problems in Adult Patients with Atrial Fibrillation on Direct Oral Anticoagulants
by: Huda Alewairdhi, et al.
Published: (2017)

Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance
by: Riccardo Vio, et al.
Published: (2021)

An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants?
by: T. V. Pavlova
Published: (2020)

Budget Impact Analysis of Anticoagulation Clinics in Patients with Atrial Fibrillation under Chronic Therapy with Oral Anticoagulants
by: William Uribe-Arango, et al.
Published: (2021)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
by: Turpie AGG
Published: (2014)

Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data
by: A. I. Listratov, et al.
Published: (2024)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021)

Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand
by: Chayanat Pongsathabordee, et al.
Published: (2024)

Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants
by: Z. A. Gebekova, et al.
Published: (2022)

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS
by: A. А. Sokolova, et al.
Published: (2017)

Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function
by: N. V. Drobotya, et al.
Published: (2020)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015)

Treated with preventive anticoagulation therapy in atrial fibrillation: The patients' perspective
by: Karin Olsson, et al.
Published: (2022)

Associations of Atrial Fibrillation Patterns With Mortality and Cardiovascular Events: Implications of the MISOAC-AF Trial
by: Amalia Baroutidou MD, et al.
Published: (2022)

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and High Thromboembolic Risk. A Systematic Review
by: Domenico Acanfora, et al.
Published: (2019)